Literature DB >> 19424603

MEK/ERK pathway mediates UVB-induced AQP1 downregulation and water permeability impairment in human retinal pigment epithelial cells.

Qin Jiang1, Cong Cao, Shan Lu, Rebecca Kivlin, Brittany Wallin, Wenming Chu, Zhigang Bi, Xinru Wang, Yinsheng Wan.   

Abstract

Aquaporins (AQPs) are a family of 13 small ( approximately 30 kDa/monomer), hydrophobic, integral membrane proteins. AQPs are expressed in various epithelial and endothelial cells involved in fluid transport. Here, we demonstrated for the first time that AQP1 is expressed in cultured human retinal pigment epithelial (RPE) cells (ARPE-19 cell line). Ultraviolet radiation (UVB) and H2O2, two major factors causing RPE cell damage, induced AQP1 downregulation which was mediated by MEK/ERK activation. UV and H2O2 as well as AQP1-specific siRNA knockdown impaired water permeability of ARPE-19 cells. Notably, pretreatment with all-trans retinoic acid attenuated UV- and H2O2-induced AQP1 downregulation and water permeability impairment. Considering that water permeability is involved in multiple functions of RPE cells such as cellular junction formation, fluid or protein exchange and barrier formation, our data elucidated a novel mechanism through which UV radiation and oxidative stress induce eye cell damage. Our results further support the notion that all-trans retinoic acid might be useful for protection against UV or oxidative stress-induced eye cell damage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19424603     DOI: 10.3892/ijmm_00000191

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  23 in total

1.  Ocular Toxicity Profile of ST-162 and ST-168 as Novel Bifunctional MEK/PI3K Inhibitors.

Authors:  Andrew Smith; Mercy Pawar; Marcian E Van Dort; Stefanie Galbán; Amanda R Welton; Greg M Thurber; Brian D Ross; Cagri G Besirli
Journal:  J Ocul Pharmacol Ther       Date:  2018-04-30       Impact factor: 2.671

2.  Clinical and Morphologic Characteristics of MEK Inhibitor-Associated Retinopathy: Differences from Central Serous Chorioretinopathy.

Authors:  Jasmine H Francis; Larissa A Habib; David H Abramson; Lawrence A Yannuzzi; Murk Heinemann; Mrinal M Gounder; Rachel N Grisham; Michael A Postow; Alexander N Shoushtari; Ping Chi; Neil H Segal; Rona Yaeger; Alan L Ho; Paul B Chapman; Federica Catalanotti
Journal:  Ophthalmology       Date:  2017-07-12       Impact factor: 12.079

Review 3.  MEK inhibitors: a new class of chemotherapeutic agents with ocular toxicity.

Authors:  K E Duncan; L Y Chang; M Patronas
Journal:  Eye (Lond)       Date:  2015-06-05       Impact factor: 3.775

4.  [Serous retinopathy: an important adverse event in tumor treatment].

Authors:  I Lüdeke; P Terheyden; S Grisanti; M Lüke
Journal:  Ophthalmologe       Date:  2017-04       Impact factor: 1.059

5.  FREQUENT SUBCLINICAL MACULAR CHANGES IN COMBINED BRAF/MEK INHIBITION WITH HIGH-DOSE HYDROXYCHLOROQUINE AS TREATMENT FOR ADVANCED METASTATIC BRAF MUTANT MELANOMA: Preliminary Results From a Phase I/II Clinical Treatment Trial.

Authors:  Akosua A Nti; Leona W Serrano; Harpal S Sandhu; Katherine E Uyhazi; Ilaina D Edelstein; Elaine J Zhou; Scott Bowman; Delu Song; Tara C Gangadhar; Lynn M Schuchter; Sheryl Mitnick; Alexander Huang; Charles W Nichols; Ravi K Amaravadi; Benjamin J Kim; Tomas S Aleman
Journal:  Retina       Date:  2019-03       Impact factor: 4.256

6.  [Cobimetinib/vemurafenib-associated bilateral serous retinopathy: a case report].

Authors:  Gregor Kastl
Journal:  Ophthalmologe       Date:  2019-08       Impact factor: 1.059

7.  Wild chrysanthemum extract prevents UVB radiation-induced acute cell death and photoaging.

Authors:  Sujiao Sun; Ping Jiang; Weiting Su; Yang Xiang; Jian Li; Lin Zeng; Shuangjuan Yang
Journal:  Cytotechnology       Date:  2014-07-23       Impact factor: 2.058

8.  Aquaporin-1 translocation and degradation mediates the water transportation mechanism of acetazolamide.

Authors:  Jianzhao Zhang; Yu An; Junwei Gao; Jing Han; Xueyang Pan; Yan Pan; Lu Tie; Xuejun Li
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

9.  Bilateral Serous Retinal Detachment Associated with a Mitogen-activated Protein KinaseKinase Inhibitor in a Patient with BRAF-mutant Colorectal Cancer.

Authors:  Miho Sakumura; Takayuki Ando; Tomoko Ueda-Consolvo; Iori Motoo; Hiroshi Mihara; Shinya Kajiura; Akira Teramoto; Sohachi Nanjo; Haruka Fujinami; Ichiro Yasuda
Journal:  Intern Med       Date:  2021-10-26       Impact factor: 1.282

10.  Bilateral Multifocal Central Serous-Like Chorioretinopathy due to MEK Inhibition for Metastatic Cutaneous Melanoma.

Authors:  Scott D Schoenberger; Stephen J Kim
Journal:  Case Rep Ophthalmol Med       Date:  2013-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.